CAMLG expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.446400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.817500E-02
Normal-vs-Stage2
7.590200E-01
Normal-vs-Stage3
4.319400E-01
Normal-vs-Stage4
2.493000E-01
Stage1-vs-Stage2
1.522640E-01
Stage1-vs-Stage3
3.025600E-02
Stage1-vs-Stage4
5.894800E-01
Stage2-vs-Stage3
1.718010E-01
Stage2-vs-Stage4
3.316400E-02
Stage3-vs-Stage4
1.086410E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.542200E-01
Normal-vs-AfricanAmerican
9.779000E-01
Normal-vs-Asian
5.755800E-01
Caucasian-vs-AfricanAmerican
5.508200E-01
Caucasian-vs-Asian
9.932400E-01
AfricanAmerican-vs-Asian
5.248400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.331600E-01
Normal-vs-Female
6.642200E-01
Male-vs-Female
8.244200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.940200E-01
Normal-vs-Age(41-60Yrs)
2.967800E-01
Normal-vs-Age(61-80Yrs)
8.590200E-01
Normal-vs-Age(81-100Yrs)
4.620400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.236800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.522600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.523200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.895100E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.291600E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.877400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.913400E-01
Normal-vs-Daily Drinker
5.261600E-01
Normal-vs-Weekly Drinker
7.315600E-01
Normal-vs-Occasional Drinker
3.094800E-01
Normal-vs-Social Drinker
6.797800E-01
Non Drinker-vs-Daily Drinker
7.706100E-02
Non Drinker-vs-Weekly Drinker
3.742800E-01
Non Drinker-vs-Occasional Drinker
1.222310E-02
Non Drinker-vs-Social Drinker
2.609200E-01
Daily Drinker-vs-Weekly Drinker
4.825800E-01
Daily Drinker-vs-Occasional Drinker
5.105800E-01
Daily Drinker-vs-Social Drinker
6.567000E-01
Weekly Drinker-vs-Occasional Drinker
1.771950E-01
Weekly Drinker-vs-Social Drinker
8.129800E-01
Occasional Drinker-vs-Social Drinker
2.924200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.349700E-02
Normal-vs-Grade 2
5.835900E-04
Normal-vs-Grade 3
2.557100E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.279600E-01
Grade 1-vs-Grade 3
7.793400E-01
Grade 1-vs-Grade 4
5.349700E-02
Grade 2-vs-Grade 3
2.496000E-01
Grade 2-vs-Grade 4
5.835900E-04
Grade 3-vs-Grade 4
2.557100E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.021600E-01
Normal-vs-NonDiabetic
6.206000E-01
Diabetic-vs-NonDiabetic
8.276000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.946400E-01
Normal-vs-NoPancreatitis
6.530600E-01
Pancreatitis-vs-NoPancreatitis
3.075600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.912200E-01
Normal-vs-N1
7.721800E-01
N0-vs-N1
1.390000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.976000E-01
Normal-vs-TP53-NonMutant
1.716390E-01
TP53-Mutant-vs-TP53-NonMutant
5.449600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
